Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ori 9020
2. Ori-9020
3. Ori9020
1. Ori-9020
2. 475650-36-3
3. Sb-40
4. Tq0a9fiv71
5. O-(((2r,3s,5r)-5-(6-amino-9h-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methyl) O-((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-yl) S-hydrogen Phosphorothioate
6. 2'-o-methyl-p-thiouridylyl-(3'->5')-2'-deoxyadenosine
7. Adenosine, 2'-o-methyl-p-thiouridylyl-(3'->5')-2'-deoxy-
8. Unii-tq0a9fiv71
9. Chembl1084430
10. Ex-a3427
11. Mfcd31727872
12. Inarigivir(ori-9020,sb-9000)
13. Db15062
14. 1-[(2r,3r,4r,5r)-4-[[(2r,3s,5r)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione
15. Ac-36511
16. Hy-101954
17. Cs-0022217
18. D70024
19. 2'-o-methyl-p-thiouridylyl-(3',5')-2'-deoxy-adenosine
20. 2'-o-methyl-p-thiouridylyl-(3'?5')-2'-deoxy-adenosine
21. 5'-o-[hydroxy(2'-o-methyl-3'-uridyloxy)thiophophinyl]-2'-deoxyadenosine
22. 1-[(2r,3r,4r,5r)-4-[[(2r,3s,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-tetrahydrofuran-2-yl]methoxy-sulfanyl-phosphoryl]oxy-5-(hydroxymethyl)-3-methoxy-tetrahydrofuran-2-yl]pyrimidine-2,4-dione
| Molecular Weight | 587.5 g/mol |
|---|---|
| Molecular Formula | C20H26N7O10PS |
| XLogP3 | -1.8 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 9 |
| Exact Mass | 587.11994822 g/mol |
| Monoisotopic Mass | 587.11994822 g/mol |
| Topological Polar Surface Area | 258 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 1010 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
93
PharmaCompass offers a list of Inarigivir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Inarigivir manufacturer or Inarigivir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Inarigivir manufacturer or Inarigivir supplier.
PharmaCompass also assists you with knowing the Inarigivir API Price utilized in the formulation of products. Inarigivir API Price is not always fixed or binding as the Inarigivir Price is obtained through a variety of data sources. The Inarigivir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Inarigivir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Inarigivir, including repackagers and relabelers. The FDA regulates Inarigivir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Inarigivir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Inarigivir supplier is an individual or a company that provides Inarigivir active pharmaceutical ingredient (API) or Inarigivir finished formulations upon request. The Inarigivir suppliers may include Inarigivir API manufacturers, exporters, distributors and traders.
Inarigivir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Inarigivir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Inarigivir GMP manufacturer or Inarigivir GMP API supplier for your needs.
A Inarigivir CoA (Certificate of Analysis) is a formal document that attests to Inarigivir's compliance with Inarigivir specifications and serves as a tool for batch-level quality control.
Inarigivir CoA mostly includes findings from lab analyses of a specific batch. For each Inarigivir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Inarigivir may be tested according to a variety of international standards, such as European Pharmacopoeia (Inarigivir EP), Inarigivir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Inarigivir USP).
